24 research outputs found
SVR and RVR rates according to INF-L3 and HCV genotype.
<p><b>(A)</b> SVR rates in relation to IFNL3 genotype (PP analysis). (B) RVR rates in relation to IFNL3 genotype (PP analysis). (C) SVR rates in relation to IFNL3 genotype in HCV genotype 2 patients. (D) SVR rates in relation to IFNL3 genotype in HCV genotype 3 patients. (E) RVR rates in relation to IFNL3 genotype in HCV genotype 3 patients. (F) RVR rates in relation to IFNL3 genotype in HCV genotype 2 patients.</p
Flow chart of patients with available IFNL3 and IFN-L4 genotype.
<p>Flow chart of patients with available IFNL3 and IFN-L4 genotype.</p
HCV RNA levels at baseline according to IFNL3 genotypes.
<p>(A) HCV RNA levels at baseline for patients with favourable and non-favorable rs1297860 genotype. (B) HCV RNA levels at baseline for patients with favourable and non-favorable rs8099917 genotype.</p
RVR in HCV genotype 3 according to baseline viral load in relation to IFNL3 genotype.
<p>RVR in HCV genotype 3 according to baseline viral load in relation to IFNL3 genotype.</p
Baseline characteristics of all randomized patients at study initiation.
<p>* In Delgard et al., 400.000IU/mL was used as cut-off for high and low viral load</p><p>Baseline characteristics of all randomized patients at study initiation.</p
Virological response rates at EOT, FU12 and FU24 in the ITT, mITT and completer population.
<p>Virological response rates at EOT, FU12 and FU24 in the ITT, mITT and completer population.</p